IDH1 and glioma: Moreover, when WHO grade (Supplementary Figure S3E), IDH status (Supplementary Figure S3F) and 1p/19q status (Supplementary Figure S3G) were added as sub-classifiers, the reactive astrocyte scores of recurrent glioma samples were significantly higher than those of primary glioma samples in the same subset.